SOUTH SAN FRANCISCO, Calif. and MONROVIA, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel ...
Tiziana Life Sciences Ltd. (NASDAQ: TLSA) recently announced the Company has initiated site selection for its lead intranasal anti-CD3 monoclonal antibody drug candidate “foralumab” program entering ...
On September 8, 2021 following the market close, Tiziana Life Sciences TLSA hosted a web conference centered on its recent exclusive license agreement with Precision BioSciences DTIL for foralumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback